| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1782 |
| Trial ID | NCT03281551 |
| Disease | B-Cell Lymphoma | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PZ01 CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma |
| Year | 2017 |
| Country | China |
| Company sponsor | Pinze Lifetechnology Co. Ltd. |
| Other ID(s) | PZ01 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||